Abstract
A population-based, case-control study was conducted in Los Angeles County, California, to investigate the inter-relationships of obesity, hypertension and medications in relation to renal cell carcinoma (RCC) risk. A total of 1204 RCC patients and an equal number of neighbourhood controls were included. Obesity was a strong risk factor for RCC. A fourfold increase in risk was observed for those with usual body mass index (kg m(-2)) of > or = 30 vs < 22. A history of hypertension was another strong, independent risk factor for RCC [odds ratio (OR) = 2.2; 95% confidence interval (CI) = 1.8, 2.6]. There was little evidence that use of diuretics was directly related to RCC development. Use of diuretics for reasons other than hypertension (primarily for weight control) was unrelated to risk among self-reported normotensive subjects (OR = 1.2; 95% CI = 0.7, 2.2). Among hypertensive subjects, heavy users of diuretics experienced similar risk as light users (OR = 0.9 among subjects with lifetime dose of > or = 137 g compared with those with lifetime dose of < 43 g). Similarly, normotensive subjects who took non-diuretic antihypertensives regularly showed no increased risk for RCC (OR = 1.1; 95% CI = 0.6-1.8), and intake among hypertensive subjects did not further increase their risk. Regular use of amphetamine-containing diet pills was associated with a twofold increase in RCC risk (95% CI = 1.4-2.8) and the risk increased with increasing dose of amphetamines. However, the fraction of cases possibly related to this exposure is small (population-attributable risk = 5%).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yuan, JM., Castelao, J., Gago-Dominguez, M. et al. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 77, 1508–1513 (1998). https://doi.org/10.1038/bjc.1998.248
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.248
This article is cited by
-
Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes
Nature Reviews Urology (2023)
-
Early life body size in relation to risk of renal cell carcinoma in adulthood: a Danish observational cohort study
European Journal of Epidemiology (2020)
-
Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies
Scientific Reports (2019)
-
Antihypertensive medication use and risk of renal cell carcinoma
Cancer Causes & Control (2017)
-
Association of hypertension and obesity with renal cell carcinoma risk: a report from the Shanghai Men’s and Women’s Health Studies
Cancer Causes & Control (2015)